AKT1 and schizophrenia: In a dopamine transporter knockout mouse model of schizophrenia, acute treatment with PREGS was able to rescue behavioral anomalies through the NMDA receptor‐mediated AKT/GSK3β signaling pathway (Wong et al., 2015).